Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact on +44 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Testimonials
I just wanted to express my thanks for all the help and guidance Zenopa have provided me with over the past month. Zenopa have been very helpful throughout the interview and negotiation stages.
Allira, 2012

Teva announces CEO succession plan

3 January 2012 00:00 in Pharmacy Supplier News


Teva has announced that Dr Jeremy Levin will succeed Shlomo Yanai as president and chief executive officer (CEO) of the company in May 2012.

The generic medicines specialist is appointing Dr Levin, a former senior executive for Bristol-Myers Squibb, based on his background of more than 25 years industry experience, as well as his leadership in creating research and business collaborations.

Prior to his spell with Bristol-Myers Squibb, he served as a global head of business development and strategic alliances at Novartis and as chief executive office of Cadus Pharmaceuticals.

He will take over from Mr Yanai following the current CEO's retirement from the company in order to pursue new business opportunities.

Dr Phillip Frost, chairman of the board of directors at Teva, said: "We wish him the best in his new endeavours and are appreciative that he will continue to be a valued advisor to the company following the leadership change."

This follows the appointment of Dr Rob Koremans as president and chief executive officer of its European division last month.ADNFCR-8000103-ID-801254140-ADNFCR

Other news stories from 03/01/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd